Joel Moss

42.0k total citations
642 papers, 28.9k citations indexed

About

Joel Moss is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Joel Moss has authored 642 papers receiving a total of 28.9k indexed citations (citations by other indexed papers that have themselves been cited), including 266 papers in Molecular Biology, 197 papers in Immunology and 189 papers in Oncology. Recurrent topics in Joel Moss's work include Toxin Mechanisms and Immunotoxins (152 papers), Tuberous Sclerosis Complex Research (140 papers) and PARP inhibition in cancer therapy (122 papers). Joel Moss is often cited by papers focused on Toxin Mechanisms and Immunotoxins (152 papers), Tuberous Sclerosis Complex Research (140 papers) and PARP inhibition in cancer therapy (122 papers). Joel Moss collaborates with scholars based in United States, Japan and Italy. Joel Moss's co-authors include Martha Vaughan, M Vaughan, Angelo M. Taveira‐DaSilva, Peter H. Fishman, Gustavo Pacheco–Rodriguez, S.J. Stanley, Victor J. Ferrans, Ronald Adamik, William D. Travis and Jiro Kato and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Joel Moss

633 papers receiving 27.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Joel Moss 12.8k 6.8k 6.4k 6.4k 5.4k 642 28.9k
Junying Yuan 36.5k 2.8× 4.3k 0.6× 5.1k 0.8× 10.4k 1.6× 8.1k 1.5× 254 52.9k
Guy S. Salvesen 37.2k 2.9× 5.7k 0.8× 9.0k 1.4× 9.6k 1.5× 5.5k 1.0× 295 54.7k
Eric Verdin 24.9k 1.9× 11.0k 1.6× 5.1k 0.8× 5.8k 0.9× 1.8k 0.3× 279 47.7k
Eileen White 26.5k 2.1× 2.2k 0.3× 7.5k 1.2× 4.0k 0.6× 4.8k 0.9× 241 41.1k
John Blenis 39.2k 3.1× 4.7k 0.7× 8.2k 1.3× 6.5k 1.0× 6.3k 1.2× 222 51.9k
Keiji Tanaka 37.9k 3.0× 4.3k 0.6× 7.5k 1.2× 6.8k 1.1× 11.5k 2.1× 428 55.1k
Yusuf A. Hannun 51.4k 4.0× 10.9k 1.6× 4.2k 0.7× 6.2k 1.0× 13.5k 2.5× 570 62.0k
Tamotsu Yoshimori 24.4k 1.9× 5.5k 0.8× 1.6k 0.3× 5.9k 0.9× 14.1k 2.6× 246 55.8k
Jiahuai Han 29.9k 2.3× 3.0k 0.4× 5.8k 0.9× 11.0k 1.7× 3.7k 0.7× 319 44.0k
Klaus Schulze‐Osthoff 17.8k 1.4× 2.4k 0.3× 4.6k 0.7× 7.3k 1.1× 2.1k 0.4× 311 29.8k

Countries citing papers authored by Joel Moss

Since Specialization
Citations

This map shows the geographic impact of Joel Moss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Moss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Moss more than expected).

Fields of papers citing papers by Joel Moss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Moss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Moss. The network helps show where Joel Moss may publish in the future.

Co-authorship network of co-authors of Joel Moss

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Moss. A scholar is included among the top collaborators of Joel Moss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Moss. Joel Moss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Acharya, Dhiraj, Maximilian Hirschenberger, Matthew A. Zurenski, et al.. (2025). TRIM23 mediates cGAS-induced autophagy in anti-HSV defense. Nature Communications. 16(1). 4418–4418. 6 indexed citations
2.
Moss, Joel, et al.. (2025). Coil Sketching for Fast and Efficient 4D Lung MRI Reconstruction. Magnetic Resonance in Medicine. 95(4). 2241–2253.
3.
Hsu, Li‐Yueh, et al.. (2024). Clinical Trial Validation of Automated Segmentation and Scoring of Pulmonary Cysts in Thoracic CT Scans. Diagnostics. 14(14). 1529–1529. 1 indexed citations
4.
Kasamatsu, Atsushi, Kohei Kawasaki, Tomoaki Saito, et al.. (2024). Synthetic Circular RNA for microRNA-1269a Suppresses Tumor Progression in Oral Squamous Cell Carcinoma. Cancers. 16(6). 1242–1242. 4 indexed citations
5.
Ohgita, Takashi, Kohei Ogura, Hiroyasu Tsutsuki, et al.. (2024). Extracellular Vesicle Inhibitors Enhance Cholix-Induced Cell Death via Regulation of the JNK-Dependent Pathway. Toxins. 16(9). 380–380.
6.
Ho, Lawrence, Nishant Gupta, Joel Moss, et al.. (2024). Unsupervised Exercise in Interstitial Lung Disease. CHEST Journal. 166(5). 1108–1123. 2 indexed citations
7.
Gibbons, Erin, Huixing Wu, Samia Lopa, et al.. (2024). Glycoprotein non-metastatic melanoma protein B promotes tumor growth and is a biomarker for lymphangioleiomyomatosis. Endocrine Related Cancer. 31(6). 6 indexed citations
8.
Klonowska, Katarzyna, Krinio Giannikou, Aaron R. Thorner, et al.. (2023). Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex. The American Journal of Human Genetics. 110(6). 979–988. 19 indexed citations
9.
Cai, Xiong, Qingyuan Fan, Xiaoyan Shen, et al.. (2021). Long-Term Effects of Sirolimus on Human Skin TSC2-Null Fibroblast‒Like Cells. Journal of Investigative Dermatology. 141(9). 2291–2299.e2. 1 indexed citations
10.
Taveira‐DaSilva, Angelo M., Thomas C. Markello, David E. Kleiner, et al.. (2018). Expanding the phenotype of COPA syndrome: a kindred with typical and atypical features. Journal of Medical Genetics. 56(11). 778–782. 39 indexed citations
11.
Julian, Lisa M., Sean P. Delaney, Ying Wang, et al.. (2017). Human Pluripotent Stem Cell–Derived TSC2 -Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis. Cancer Research. 77(20). 5491–5502. 19 indexed citations
12.
Cui, Ye, Wendy K. Steagall, Gustavo Pacheco–Rodriguez, et al.. (2017). Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation. Cancer Research. 77(6). 1492–1502. 15 indexed citations
13.
Hubbard, Basil P., Hang Dai, April Case, et al.. (2013). Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators. Science. 339(6124). 1216–1219. 20 indexed citations
14.
Kato, Jiro, Jianfeng Zhu, Chengyu Liu, et al.. (2011). ADP-Ribosylarginine Hydrolase Regulates Cell Proliferation and Tumorigenesis. Cancer Research. 71(15). 5327–5335. 40 indexed citations
15.
Berra, Lorenzo, Andrea Coppadoro, Edward A. Bittner, et al.. (2011). A clinical assessment of the Mucus Shaver. Critical Care Medicine. 40(1). 119–124. 56 indexed citations
16.
Pacheco–Rodriguez, Gustavo, et al.. (2008). Unfolded protein response and cell death after depletion of brefeldin A-inhibited guanine nucleotide-exchange protein GBF1. Proceedings of the National Academy of Sciences. 105(8). 2877–2882. 85 indexed citations
17.
Taveira‐DaSilva, Angelo M., et al.. (2004). Bone Mineral Density in Lymphangioleiomyomatosis. American Journal of Respiratory and Critical Care Medicine. 171(1). 61–67. 16 indexed citations
18.
Taveira‐DaSilva, Angelo M., Mario Stylianou, Arnold S. Kristof, et al.. (2003). Maximal Oxygen Uptake and Severity of Disease in Lymphangioleiomyomatosis. American Journal of Respiratory and Critical Care Medicine. 168(12). 1427–1431. 60 indexed citations
19.
Matsui, Kazuhiro, William Riemenschneider, Stephen L. Hilbert, et al.. (2000). Hyperplasia of Type II Pneumocytes in Pulmonary Lymphangioleiomyomatosis Immunohistochemical and Electron Microscopic Study. Archives of Pathology & Laboratory Medicine. 124(11). 1642–1648. 5 indexed citations
20.
Moss, Joel & M. Daniel Lane. (1971). The Biotin‐Dependent Enzymes. Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects. 321–442. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junying Yuan Breakdown of academic impact, for papers by Guy S. Salvesen Breakdown of academic impact, for papers by Eric Verdin Breakdown of academic impact, for papers by Eileen White Breakdown of academic impact, for papers by John Blenis Breakdown of academic impact, for papers by Keiji Tanaka Breakdown of academic impact, for papers by Yusuf A. Hannun Breakdown of academic impact, for papers by Tamotsu Yoshimori Breakdown of academic impact, for papers by Jiahuai Han Breakdown of academic impact, for papers by Klaus Schulze‐Osthoff
Rankless by CCL
2026